Sep 13, 2024
Inspira(TM) Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System
Aug 28, 2024
Inspira(TM) to Publish HYLA(TM) Clinical Results in Fourth Quarter 2024
Aug 22, 2024
Inspira(TM) Technologies Announces FDA Listing and Market Readiness of New Product
Jul 30, 2024
Inspira(TM) Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest
Jul 11, 2024
Inspira(TM) Receives Israeli Regulatory Approval for the INSPIRA(TM) ART100 System
Jun 20, 2024
Inspira(TM) Announces Business Plan Targets
Jun 17, 2024
Inspira(TM) Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel
Jun 13, 2024
Inspira(TM) Receives First Ever Purchase Order for INSPIRA(TM) ART100 Systems in the U.S.
May 30, 2024
Inspira(TM) Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
May 28, 2024
INSPIRA(TM) ART100 Receives FDA 510(k) Clearance
May 02, 2024
Inspira(TM) Announces Start of Production of the INSPIRA(TM) ART100
Apr 25, 2024
Inspira(TM) Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA(TM) ART100
Apr 16, 2024
Inspira(TM) Signs Term Sheet for Use of INSPIRA(TM) ART100 Device in Organ Transplant Procedures
Apr 03, 2024
Inspira(TM) Announces Program to Pioneer the Applicable Use of the INSPIRA(TM) ART100 Device for an Artificial Womb
Mar 25, 2024
Inspira(TM) Technologies Reports Full Year 2023 Financial Results
Mar 12, 2024
Inspira(TM) Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
Mar 04, 2024
Inspira(TM) Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
Feb 27, 2024
Inspira(TM) To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
Feb 22, 2024
Inspira(TM) introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
Feb 14, 2024
Inspira(TM) Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System